Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well acolbifene works in preventing cancer in
premenopausal women at high risk of breast cancer. Chemoprevention is the use of certain
drugs to keep cancer from forming. The use of acolbifene may stop cancer from growing or
coming back.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Institute (NCI) University of Kansas Medical Center